Overview

Bioequivalence Study of Clonazepam 2 Mg Tablets

Status:
NOT_YET_RECRUITING

Trial end date:
2025-11-01

Target enrollment:

Participant gender:

Summary

Demonstrate the bioequivalence in 1 study, in fasting condition of two formulations of clonazepam 2 mg Tablets / tablets immediate release in order to establish that there are no significant pharmacokinetic differences.

Phase:

PHASE4

Details

Lead Sponsor:

Centro de Atencion e Investigacion Medica

Treatments:

Clonazepam